Michael Jerman, CPA.
Board Member
Inhibitor Therapeutics, Inc. (INTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Jerman, CPA.
Michael Jerman, CPA. is recorded as Board Member at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed May 31, 2023 that Michael Jerman, CPA. was appointed independent member of its Board, effective May 24, 2023.
“On May 24, 2023, the Board of the Company appointed Michael Jerman, CPA. as an independent member of its Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibitor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis E. O'Donnell CEO, Board Member
- Francis E. O'Donnell, Jr. CEO, Chairman
- Francis E. O'Donnell, Jr., M.D. CEO, Chairman
- James A. McNulty CFO
- James A. McNulty, CPA CFO
- Michael Jerman Board Member
- Michelle Yanez Board Member
- Michelle Yanez, MBA Board Member
- Niraj Vasisht Board Member
- Niraj Vasisht, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.